Siebermair, J.
Neumann, B.
Risch, F.
Riesinger, L.
Vonderlin, N.
Koehler, M.
Lackermaier, K.
Fichtner, S.
Rizas, K.
Sattler, S. M. http://orcid.org/0000-0003-3558-8329
Sinner, M. F.
Kääb, S.
Estner, H. L.
Wakili, R.
Article History
Received: 25 September 2018
Accepted: 29 May 2019
First Online: 20 June 2019
Competing Interests
: Reza Wakili has received consultant fees and travel expenses from Boston Scientific; consultant fees from Biotronik; investigator-initiated funding for research projects (initiated by him) from Bristol-Myers Squibb, Pfizer, and Boston Scientific; and speaking honoraria from Boston Scientific. Moritz F. Sinner has received training support from St. Jude (now Abbott), Boston Scientific, and Biotronik. The other authors declare no competing interests.